A Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in Culture
暂无分享,去创建一个
J. Delaissé | K. Søe | D. Brömme | M. Overgaard | J. S. Madsen | M. L. Bergmann | Preety Panwar | D. C. Pirapaharan | J. Madsen | P. Panwar
[1] C. Overall,et al. Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases. , 2017, Matrix biology : journal of the International Society for Matrix Biology.
[2] J. Delaissé,et al. An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] S. Khosla,et al. Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned , 2017, Endocrine reviews.
[4] J. Delaissé,et al. Osteoclast Fusion: Time‐Lapse Reveals Involvement of CD47 and Syncytin‐1 at Different Stages of Nuclearity , 2016, Journal of cellular physiology.
[5] N. Chattopadhyay,et al. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy. , 2016, Biochemical pharmacology.
[6] D. Brömme,et al. Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences , 2016, Expert opinion on drug discovery.
[7] J. Delaissé,et al. A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K , 2016, British journal of pharmacology.
[8] M. Ding,et al. Pit- and trench-forming osteoclasts: a distinction that matters , 2015, Bone Research.
[9] G. Brayer,et al. Structural basis of collagen fiber degradation by cathepsin K , 2014, Proceedings of the National Academy of Sciences.
[10] L. Duong,et al. Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible. , 2014, Bone.
[11] J. Delaissé,et al. Steering the osteoclast through the demineralization-collagenolysis balance. , 2013, Bone.
[12] Hongbin Li,et al. Effects of Cysteine Proteases on the Structural and Mechanical Properties of Collagen Fibers* , 2013, The Journal of Biological Chemistry.
[13] L. Duong. Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation. , 2012, BoneKEy reports.
[14] L. Duong,et al. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. , 2011, Bone.
[15] J. Delaissé,et al. Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] J. Eisman,et al. Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] M. Percival,et al. Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools , 2009, Biological chemistry.
[18] M. Kumegawa,et al. Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR , 2007, Calcified Tissue International.
[19] C. Peters,et al. Osteoclastic Bone Degradation and the Role of Different Cysteine Proteinases and Matrix Metalloproteinases: Differences Between Calvaria and Long Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] J. Falgueyret,et al. Identification of a potent and selective non-basic cathepsin K inhibitor. , 2006, Bioorganic & medicinal chemistry letters.
[21] E. Vuorio,et al. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. , 2005, Bone.
[22] V. Bhalla,et al. inhibition in , 2005 .
[23] J. Delaissé,et al. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. , 2004, Bone.
[24] R. Maciewicz,et al. Cathepsin L‐deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy , 2004, International journal of experimental pathology.
[25] D. Brömme,et al. Production and activation of recombinant papain-like cysteine proteases. , 2004, Methods.
[26] J. Delaissé,et al. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities , 2003, Microscopy research and technique.
[27] M. Karsdal,et al. The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] P. Saftig,et al. The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] M. Kumegawa,et al. Erratum to: Quantification of the Expression Levels of Lysosomal Cysteine Proteinases in Purified Human Osteoclastic Cells by Competitive RT-PCR , 2001, Calcified Tissue International.
[30] Y. Ru,et al. Potent and Selective Cathepsin L Inhibitors Do Not Inhibit Human Osteoclast Resorption in Vitro * , 2001, The Journal of Biological Chemistry.
[31] Thiennu H. Vu,et al. Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.
[32] J. Palmer,et al. Localization of Rat Cathepsin K in Osteoclasts and Resorption Pits: Inhibition of Bone Resorption and Cathepsin K-Activity by Peptidyl Vinyl Sulfones , 1999, Biological chemistry.
[33] P. Delmas,et al. The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* , 1998, The Journal of Biological Chemistry.
[34] Sheila J. Jones,et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] L. Creemers,et al. Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[36] Y. Okada,et al. Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.
[37] Jian Zhang,et al. Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. , 1996, Biochemical and molecular medicine.
[38] C. Debouck,et al. Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*) , 1996, The Journal of Biological Chemistry.
[39] J. Mort,et al. The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[40] Sheila J. Jones,et al. Inhibition of bone resrption by selctive inactivators of cysteine proteinases , 1994, Journal of cellular biochemistry.
[41] P. Tulkens,et al. Increased activities of cathepsin B and other lysosomal hydrolases in fibroblasts and bone tissue cultured in the presence of cysteine proteinases inhibitors. , 1994, Life sciences.
[42] Bonnie F. Sloane,et al. Human tumour cathepsin B. Comparison with normal liver cathepsin B. , 1992, The Biochemical journal.
[43] J. Delaissé,et al. Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases , 1992, Journal of cellular physiology.
[44] R. Maciewicz,et al. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L , 1990, FEBS letters.
[45] V. Sukhatme,et al. Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. , 1989, The Biochemical journal.
[46] T. Tsukahara,et al. Autodegradation of lysosomal cysteine proteinases. , 1987, Biochemical and biophysical research communications.
[47] Sheila J. Jones,et al. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. , 1987, Bone.
[48] J. Sutherland,et al. Paradoxical effect of leupeptin in vivo on cathepsin B activity. , 1983, Biochemical and biophysical research communications.
[49] N. Ikegaki,et al. Effects of leupeptin and pepstatin on protein turnover in adult rat hepatocytes in primary culture. , 1981, Archives of biochemistry and biophysics.